Type Ⅱ diabetes is a chronic disease

● Affects more than 320 million people worldwide

● Is the fourth or fifth leading cause of death


The incidence is increasing accelerately !

Good news is that Type Ⅱ diabetes can be effectively treated with acarbose, an anti-diabetic drug produced by actinomycetes.


Actinomycetes remain the most important source of new antibiotics in nearly a decade of investigations .


However

The search for high yielding strains through experimentation is a long process


We have therefore developed an integrated software that combines

Simulate

the growth and metabolism of actinomycetes

Predict

phenotypic changes after mutation

Provide

high yielding transformation solutions